Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessika Suescun

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Parkinson'S Disease|September 28, 2017
Earlier Intervention with Deep Brain Stimulation for Parkinson's DiseaseGerson Suarez-Cedeno, Jessika Suescun, Mya C Schiess
Scientific Reports|April 30, 2021
Computational medication regimen for Parkinson's disease using reinforcement learningYejin Kim, Jessika Suescun, Mya C Schiess, et al.
Frontiers in Neurology|August 28, 2020
A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's DiseaseTimothy M Ellmore, Jessika Suescun, Richard J Castriotta, et al.
Frontiers in Neuroscience|January 20, 2022
Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer's Disease ConversionDanilo Pena, Jessika Suescun, Mya Schiess, et al.
Frontiers in Neuroscience|October 23, 2019
Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven ApproachDanilo Pena, Arko Barman, Jessika Suescun, et al.
Neuroimmunomodulation|April 11, 2017
Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson DiseaseKeri Csencsits-Smith, Jessika Suescun, Kan Li, et al.
Clinical Parkinsonism & Related Disorders|February 18, 2025
Role of alpha-synuclein seed amplification assay in Parkinson's disease clinical trials: A case of misdiagnosisEmily Tharp, Juan D Martinez-Lemus, Mya C Schiess, et al.
Clinical Parkinsonism & Related Disorders|February 16, 2023
Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levelsChristopher Adams, Jessika Suescun, Anam Haque, et al.
Frontiers in Neuroscience|January 29, 2019
Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson's DiseaseÓscar Peña-Nogales, Timothy M Ellmore, Rodrigo de Luis-García, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 27, 2021
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's DiseaseMya Schiess, Jessika Suescun, Marie-Francoise Doursout, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Parkinson'S Disease|September 28, 2017
Earlier Intervention with Deep Brain Stimulation for Parkinson's DiseaseGerson Suarez-Cedeno, Jessika Suescun, Mya C Schiess
Scientific Reports|April 30, 2021
Computational medication regimen for Parkinson's disease using reinforcement learningYejin Kim, Jessika Suescun, Mya C Schiess, et al.
Frontiers in Neurology|August 28, 2020
A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's DiseaseTimothy M Ellmore, Jessika Suescun, Richard J Castriotta, et al.
Frontiers in Neuroscience|January 20, 2022
Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer's Disease ConversionDanilo Pena, Jessika Suescun, Mya Schiess, et al.
Frontiers in Neuroscience|October 23, 2019
Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven ApproachDanilo Pena, Arko Barman, Jessika Suescun, et al.
Neuroimmunomodulation|April 11, 2017
Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson DiseaseKeri Csencsits-Smith, Jessika Suescun, Kan Li, et al.
Clinical Parkinsonism & Related Disorders|February 18, 2025
Role of alpha-synuclein seed amplification assay in Parkinson's disease clinical trials: A case of misdiagnosisEmily Tharp, Juan D Martinez-Lemus, Mya C Schiess, et al.
Clinical Parkinsonism & Related Disorders|February 16, 2023
Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levelsChristopher Adams, Jessika Suescun, Anam Haque, et al.
Frontiers in Neuroscience|January 29, 2019
Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson's DiseaseÓscar Peña-Nogales, Timothy M Ellmore, Rodrigo de Luis-García, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 27, 2021
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's DiseaseMya Schiess, Jessika Suescun, Marie-Francoise Doursout, et al.
Pageof 2